Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion type Assertion NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_head.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion description "[Sensitivity for high grade dysplasia (HSIL) and invasive cancer in the EGFR study was 100%; specificity was 73.3%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_provenance.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion evidence source_evidence_literature NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_provenance.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion SIO_000772 12102125 NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_provenance.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion wasDerivedFrom befree-2016 NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_provenance.
- NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_assertion wasGeneratedBy ECO_0000203 NP359866.RAu6HJrOzqpRthA1rNIiA51yPC5zhRJHw4lE_l1osd3bk130_provenance.